{"version":"1.0","type":"link","title":"Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations.","author_name":"Cheng HH 외","author_url":"https://prs-insight.online/author/Cheng%20HH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/133262","thumbnail_width":1200,"thumbnail_height":630}